US News

Biomedical Companies Inject Innovation Into Cancer Radiotherapy

Recent U.S. Food and Drug Administration approvals of new treatments, plus promising data from some experimental medicines, are spurring venture-capital investment in new companies and prompting drugmakers to acquire radiopharmaceutical startups.

Jump To The Original Source

Facebook Comments

Check Also

U.S. FDA delays decision on Moderna’s COVID-19 vaccine for adolescents – WSJ

Published by Reuters (Reuters) -The U.S. health regulator ...

Archives